What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
Abstract In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targ...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2023-12-01
|
| Rangatū: | The Journal of Headache and Pain |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s10194-023-01698-8 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|